TALi is a digital health company founded in 2004 with the vision to create personalized experiences that enhance cognitive function and behavior through digital devices. The company has developed a platform technology targeting cognitive attention skills in early childhood through its evidence and video game-based TALi screening (DETECT®) and training (TRAIN®). This first-to-market and user-experience-focused technology places TALi at the forefront of patient experience and early intervention, positioning it as an ideal partner in the global digital health sector. The company's innovations aim to deliver non-invasive early interventions, particularly in ADHD and ASD, for predictive diagnosis and treatment across all age groups. Additionally, TALi is conducting a core research program exploring applications for individuals with Mild Cognitive Decline (MCI). With its focus on foundational advances in human cognitive function and behavior, TALi is poised to revolutionize the field of digital health. Its headquarters is located in Australia, presenting an excellent opportunity for investment in a company driving innovative solutions in the cognitive health sector.
There is no investment information
No recent news or press coverage available for TALi.